Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment for the study has ceased, as indicated by the addition 'No longer looking for participants.' The record also updates to revision v3.6.0, superseding the previous v3.5.5 revision.SummaryDifference0.2%

- Check16 days agoChange DetectedRevision: v3.5.5 is now displayed on the page, replacing Revision: v3.5.4, indicating a newer page revision rather than substantive changes to the trial record.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision: v3.5.4 was added to the page history, replacing v3.5.3 and indicating a new site build/deployment.SummaryDifference0.0%

- Check52 days agoChange DetectedThe record history gains a new entry for revision v3.5.3, indicating an updated version of the page; it replaces the prior revision v3.5.2, reflecting an administrative update to the study record.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed, updating the site version displayed on the page. This change reflects a maintenance update and does not modify trial records or visible content.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision indicator updated from v3.4.3 to v3.5.0. This reflects a system update and does not change the study data or page content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.